Replies to post #268998 on Avid Bioservices Inc (CDMO)

[vinmantoo]

Vinmantoo, you ever think about someone who already has the fast building boat load of data that PS Targeting will be an absolute requirement for the most optimal (combo treatment..) immuno-oncology SOC's and that this entity is just closing in as other Big Pharmas are continuing to spend Billions to try to catch up to IO 2.0?

I don't deal in hopium. What data are you talking about? The clinical evidence is that Bavi as an anti-PS antibody will not be the best or even a good target for as you call it, IO 2.0